Livforsakringsbolaget Skandia, Omsesidigt Organon & Co. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $477,814 - $618,808	-16,666 Reduced 57.06%	12,542 $382,000
Q3 2021 Oct 28, 2021	BUY	$28.63 - $35.64 $359,077 - $446,996	12,542 Added 75.26%	29,208 $916,000
Q2 2021 Jul 13, 2021	BUY	$28.45 - $38.0 $474,147 - $633,308	16,666 New	16,666 $505,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.